Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Zolk

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|July 7, 2009
Functionalized silicon quantum dots tailored for targeted siRNA deliveryS Klein, O Zolk, M F Fromm, et al.
Biochemical and Biophysical Research Communications|August 15, 1998
Functional coupling of overexpressed beta 1-adrenoceptors in the myocardium of transgenic miceO Zolk, H Kilter, M Flesch, et al.
The American Journal of Physiology|November 24, 1999
AT(1) receptor regulation in salt-sensitive hypertensionK Strehlow, G Nickenig, J Roeling, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2000
Increase in G(i alpha) protein accompanies progression of post-infarction remodeling in hypertensive cardiomyopathyI Kouchi, O Zolk, F Jockenhövel, et al.
The American Journal of Physiology|June 1, 1997
Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expressionG Nickenig, O Jung, K Strehlow, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 1998
Effects of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition on cardiac beta-adrenergic signal transductionM Böhm, O Zolk, M Flesch, et al.
Hypertension (Dallas, Tex. : 1979)|November 20, 1998
Chamber-specific alterations of norepinephrine uptake sites in cardiac hypertrophyM Böhm, M Castellano, M Flesch, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatinJ E Keskitalo, O Zolk, M F Fromm, et al.
Journal of Hypertension|October 10, 1997
Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathyM Flesch, F Schiffer, O Zolk, et al.
Cardiovascular Research|February 13, 2001
Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytesM Flesch, S Ettelbrück, S Rosenkranz, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|July 7, 2009
Functionalized silicon quantum dots tailored for targeted siRNA deliveryS Klein, O Zolk, M F Fromm, et al.
Biochemical and Biophysical Research Communications|August 15, 1998
Functional coupling of overexpressed beta 1-adrenoceptors in the myocardium of transgenic miceO Zolk, H Kilter, M Flesch, et al.
The American Journal of Physiology|November 24, 1999
AT(1) receptor regulation in salt-sensitive hypertensionK Strehlow, G Nickenig, J Roeling, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2000
Increase in G(i alpha) protein accompanies progression of post-infarction remodeling in hypertensive cardiomyopathyI Kouchi, O Zolk, F Jockenhövel, et al.
The American Journal of Physiology|June 1, 1997
Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expressionG Nickenig, O Jung, K Strehlow, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 1998
Effects of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition on cardiac beta-adrenergic signal transductionM Böhm, O Zolk, M Flesch, et al.
Hypertension (Dallas, Tex. : 1979)|November 20, 1998
Chamber-specific alterations of norepinephrine uptake sites in cardiac hypertrophyM Böhm, M Castellano, M Flesch, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatinJ E Keskitalo, O Zolk, M F Fromm, et al.
Journal of Hypertension|October 10, 1997
Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathyM Flesch, F Schiffer, O Zolk, et al.
Cardiovascular Research|February 13, 2001
Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytesM Flesch, S Ettelbrück, S Rosenkranz, et al.
Pageof 4